Fig. 6

The number of copy number alterations is associated with tumor origin and prognosis. a All significant CNAs in MECA tumors, grouped by origin and fusion gene status. b Number of CNAs in MECA de novo and MECA ex-PA tumors. **P < 0.01; Mann–Whitney test. n = 15 + 22. c Freedom from recurrence in patients with different number of CNAs. *P < 0.05, ****P < 0.0001; log-rank test. n = 9 (0 CNAs) + 20 (1–9 CNAs) + 8 (>9 CNAs)